References
- Laigle-Donadey F, Doz F, Delattre JY. Brainstem gliomas in children and adults. Curr Opin Oncol 2008;20(6):662–7.
- Kesari S, Kim RS, Markos V, Prognostic factors in adult brainstem gliomas: a multicenter, retrospective analysis of 101 cases. J Neurooncol 2008;88(2):175–83.
- Massimino M, Spreafico F, Biassoni V, Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience. J Neurooncol 2008;87(3):355–61.
- Rosenthal MA, Ashley DM, Drummond KJ, Brain stem gliomas: patterns of care in Victoria from 1998–2000. J Clin Neurosci 2008;15(3):237–40.
- Barami K, Lewis-Tuffin L, Anastasiadis PZ. The role of cadherins and catenins in gliomagenesis. Neurosurg Focus 2006;21(4):E13.
- Fangusaro J. Pediatric high-grade gliomas and diffuse intrinsic pontine gliomas. J Child Neurol 2009;24(11):1409–17.
- Matsuoka T, Mitomi H, Fukui N, Cluster analysis of claudin-1 and -4, E-cadherin, and beta-catenin expression in colorectal cancers. J Surg Oncol 2011;103(7):674–86.
- Matsubayashi S, Nakashima M, Kumagai K, Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Pathol Res Pract 2009;205(9):626–33.
- Rossi M, Magnoni L, Miracco C, Beta-catenin and Gli1 are prognostic markers in glioblastoma. Cancer Biol Ther 2011;11(8):753–61.
- Pu P, Zhang Z, Kang C, Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther 2009;16(4):351–61.
- MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17(1):9–26.
- Nelson WJ. Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem Soc Trans 2008;36(Pt 2):149–55.
- Kang H, Min BS, Lee KY, Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma. Ann Surg Oncol 2011;18(3):711–9.
- Onder TT, Gupta PB, Mani SA, Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008;68(10):3645–54.
- Asano K, Kubo O, Tajika Y, Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurg Rev 2000;23(1):39–44.
- Lewis-Tuffin LJ, Rodriguez F, Giannini C, Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One 2010;5(10):e13665.
- D'Urso PI, D'Urso OF, Storelli C, Retrospective protein expression and epigenetic inactivation studies of CDH1 in patients affected by low-grade glioma. J Neurooncol 2011;104(1):113–8.
- Asano K, Duntsch CD, Zhou Q, Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol 2004;70(1):3–15.
- Utsuki S, Sato Y, Oka H, Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 2002;57(3):187–92.
- Liu Q, Liu R, Kashyap MV, Brainstem glioma progression in juvenile and adult rats. J Neurosurg 2008;109(5):849–55.
- Huang D, Du X. Crosstalk between tumor cells and microenvironment via Wnt pathway in colorectal cancer dissemination. World J Gastroenterol 2008;14(12):1823–7.